Literature DB >> 24004725

Endogenous retroviruses: acquisition, amplification and taming of genome invaders.

Marie Dewannieux1, Thierry Heidmann.   

Abstract

Endogenous retroviruses are interspersed genomic elements that were generated after infectious retroviruses entered the germline of their host. They were initially identified as degenerate remnants of past infections, but new models of very recent or ongoing endogenisation are now emerging, allowing the real time investigation of the first steps of the coexistence between these elements and their host. Domestication of endogenous retroviruses involves several mechanisms, including transcriptional control of these elements and regulation of their mobility through the action of restriction factors. Recent studies also point towards an until-now unexpected role of the immune system for the control of these elements, even those that do not contain fully infectious copies.
Copyright © 2013 Elsevier B.V. All rights reserved.

Mesh:

Year:  2013        PMID: 24004725     DOI: 10.1016/j.coviro.2013.08.005

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  52 in total

1.  HEMO, an ancestral endogenous retroviral envelope protein shed in the blood of pregnant women and expressed in pluripotent stem cells and tumors.

Authors:  Odile Heidmann; Anthony Béguin; Janio Paternina; Raphaël Berthier; Marc Deloger; Olivia Bawa; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 2.  Immune responses to endogenous retroelements: taking the bad with the good.

Authors:  George Kassiotis; Jonathan P Stoye
Journal:  Nat Rev Immunol       Date:  2016-04       Impact factor: 53.106

Review 3.  Sequence-Specific Sensing of Nucleic Acids.

Authors:  Nicolas Vabret; Nina Bhardwaj; Benjamin D Greenbaum
Journal:  Trends Immunol       Date:  2016-11-14       Impact factor: 16.687

4.  Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.

Authors:  Paul Dembny; Andrew G Newman; Manvendra Singh; Michael Hinz; Michal Szczepek; Christina Krüger; Robert Adalbert; Omar Dzaye; Thorsten Trimbuch; Thomas Wallach; Gunnar Kleinau; Katja Derkow; Bernhard C Richard; Carola Schipke; Claus Scheidereit; Harald Stachelscheid; Douglas Golenbock; Oliver Peters; Michael Coleman; Frank L Heppner; Patrick Scheerer; Victor Tarabykin; Klemens Ruprecht; Zsuzsanna Izsvák; Jens Mayer; Seija Lehnardt
Journal:  JCI Insight       Date:  2020-04-09

5.  Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review.

Authors:  Michal Chovanec; Fadi Taza; Maitri Kalra; Noah Hahn; Kenneth P Nephew; Michael J Spinella; Costantine Albany
Journal:  Target Oncol       Date:  2018-02       Impact factor: 4.493

Review 6.  Co-option of endogenous viral sequences for host cell function.

Authors:  John A Frank; Cédric Feschotte
Journal:  Curr Opin Virol       Date:  2017-08-16       Impact factor: 7.090

7.  Molecular Properties and Evolutionary Origins of a Parvovirus-Derived Myosin Fusion Gene in Guinea Pigs.

Authors:  Ignacio Valencia-Herrera; Fernando Faunes; Eduardo Cena-Ahumada; Rodrigo Ibarra-Karmy; Robert J Gifford; Gloria Arriagada
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

Review 8.  Molecular functions of human endogenous retroviruses in health and disease.

Authors:  Maria Suntsova; Andrew Garazha; Alena Ivanova; Dmitry Kaminsky; Alex Zhavoronkov; Anton Buzdin
Journal:  Cell Mol Life Sci       Date:  2015-06-18       Impact factor: 9.261

Review 9.  Altering Genomic Integrity: Heavy Metal Exposure Promotes Transposable Element-Mediated Damage.

Authors:  Maria E Morales; Geraldine Servant; Catherine Ade; Astrid M Roy-Engel
Journal:  Biol Trace Elem Res       Date:  2015-03-14       Impact factor: 3.738

10.  The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity.

Authors:  Cécile Lemaître; Francis Harper; Gérard Pierron; Thierry Heidmann; Marie Dewannieux
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.